Latest Funding News

Dimerix Limited has completed recruitment for its pivotal ACTION3 Phase 3 trial targeting a rare kidney disease, secured positive FDA feedback on trial endpoints, and reported a solid cash position of AU$38.5 million at the end of 2025.

OD6 Metals has reported significant progress in its rare earth and copper projects, unveiling a high-recovery processing flowsheet and identifying promising new copper conductors near historic workings.

Skylark Minerals Limited reported a $706,000 operating cash outflow and a $6.4 million investment in exploration during the December 2025 quarter, ending with $2.9 million in cash. The company’s financing activities provided a $3.3 million inflow, supporting its ongoing operations.

6K Additive reported a strong finish to 2025 with a 25% revenue jump in Q4 and secured $31.4 million in IPO proceeds to fuel a fivefold production expansion. The company also landed a $27.4 million US government-backed loan, positioning it for accelerated growth in the additive manufacturing sector.

Sunrise Energy Metals advances its Syerston Scandium Project with a robust updated Ore Reserve supporting a 32-year mine life, alongside significant financing commitments and a strategic offtake option with Lockheed Martin.

MONEYME has reported a robust second quarter with a 26% increase in its loan book to $1.75 billion and a 19% rise in revenue to $60 million, underpinned by improved credit quality and strategic funding initiatives.

Galan Lithium has raised A$40 million through an institutional placement to expand production at its Hombre Muerto West project by 30%, aiming for first lithium output in the first half of 2026.

Bannerman Energy reports steady progress on its Etango Uranium Project with key construction milestones met and a strong cash position, while uranium market fundamentals continue to strengthen. The company targets a positive Final Investment Decision within the next 6 to 12 months.

Image Resources NL reported a strong finish to 2025 with record heavy mineral concentrate production and sales, alongside promising developments in its gold exploration and synthetic rutile innovation.

Cynata Therapeutics has completed enrolment in major clinical trials for osteoarthritis and acute graft versus host disease, with pivotal results expected in the second quarter of 2026. The company also strengthened its patent portfolio and secured additional funding to extend its operational runway.

MEC Resources has bolstered its stake in Advent Energy with a $1.55 million loan while navigating a pivotal Federal Court hearing on the PEP 11 Joint Venture. Meanwhile, progress on Clean Hydrogen Technology signals potential growth avenues.

Bass Oil Limited reported a 7.9% rise in quarterly oil sales revenue and a 7.4% increase in production, alongside a pivotal gas sales agreement with Origin Energy for the Vanessa gas field, pending regulatory approval.